Ollagnier M, Decousus H, Cherrah Y, Levi F, Mechkouri M, Queneau P, Reinberg A
Clin Pharmacokinet. 1987 May;12(5):367-78. doi: 10.2165/00003088-198712050-00003.
Several investigations which have taken treatment time into account have shown that the pharmacokinetic parameters, the therapeutic efficacy and even the toxicity of a large number of products may vary according to the administration schedule. The present study was carried out in order to evaluate any circadian changes in pharmacokinetic parameters of ketoprofen, a new non-steroidal anti-inflammatory drug (NSAID). This randomised crossover study consisted of a single oral dose of ketoprofen 100mg administered to 8 healthy male volunteers, mean age 27.2 years, at 07.00 hours, 13.00 hours, 19.00 hours or 01.00 hours in 4 study periods during the first 3 months of the year. The order of administration was randomised, with each subject acting as his own control. A total of 14 blood and 4 urine samples were taken over a 12-hour period. The peak plasma concentration was twice as high after drug administration at 07.00 hours (13.4 +/- 1 mg/L) than after other administration times (13.00 hours: 6.9 +/- 1; 19.00 hours: 7.2 +/- 0.7; 01.00 hours: 6.3 +/- 0.5 mg/L) [p less than 0.001]. The time to reach peak concentration was much longer after drug administration at 01.00 hours (135 +/- 16.7 min) than at 07.00 (73.1 +/- 14.1 min), 13.00 (75 +/- 16.5 min) or 19.00 hours (82.5 +/- 12.7 min) [p less than 0.05]. The lag time was significantly longer at 01.00 hours than at 13.00 hours (p less than 0.01). The absorption rate constant after treatment at 01.00 hours was less than at the other times of administration (p less than 0.05). The bodyweight-corrected area under the curve (AUC0-12) was greater after 07.00 hours than after 13.00 (p less than 0.01) or 19.00 hours (p less than 0.05) and greater after 01.00 hours than after 13.00 hours (p less than 0.05). The elimination half-life was significantly longer after administration at 01.00 hours than after 19.00 hours (p less than 0.05), while the total clearance was lowest at 07.00 hours. Cosinor analysis demonstrated statistically significant circadian rhythms for all pharmacokinetic parameters described above. The amount of ketoprofen eliminated in the urine was delayed, and was significantly greater after the administration at 01.00 hours than 07.00 hours or 19.00 hours (p less than 0.01). The relationship between absorption, diffusion and/or elimination mechanisms of the drug are discussed.
几项将治疗时间考虑在内的研究表明,许多药物的药代动力学参数、治疗效果甚至毒性可能会因给药时间表而异。本研究旨在评估新型非甾体抗炎药(NSAID)酮洛芬药代动力学参数的昼夜变化。这项随机交叉研究包括在一年的前3个月的4个研究期间,给8名健康男性志愿者(平均年龄27.2岁)单次口服100mg酮洛芬,给药时间分别为07:00、13:00、19:00或01:00。给药顺序是随机的,每个受试者作为自己的对照。在12小时内共采集了14份血液和4份尿液样本。药物在07:00给药后的血浆峰值浓度(13.4±1mg/L)是其他给药时间后(13:00:6.9±1;19:00:7.2±0.7;01:00:6.3±0.5mg/L)的两倍[p<0.001]。药物在01:00给药后达到峰值浓度的时间(135±16.7分钟)比在07:00(73.1±14.1分钟)、13:00(75±16.5分钟)或19:00(82.5±12.7分钟)给药后长得多[p<0.05]。01:00的滞后时间明显长于13:00(p<0.01)。01:00治疗后的吸收速率常数低于其他给药时间(p<0.05)。体重校正曲线下面积(AUC0 - 12)在07:00后大于13:00(p<0.01)或19:00后(p<0.05),在01:00后大于13:00后(p<0.05)。01:00给药后的消除半衰期明显长于19:00给药后(p<0.05),而总清除率在07:00时最低。余弦分析表明上述所有药代动力学参数具有统计学上显著的昼夜节律。酮洛芬在尿液中的消除量延迟,且在01:00给药后明显大于07:00或19:00给药后(p<0.01)。文中讨论了药物吸收、扩散和/或消除机制之间的关系。